Smart Meter, LLC, makers of the iGlucose® Cellular Diabetes Care Solution, announced its integration with Validic, the healthcare industry’s leading data connectivity platform. Together, the companies bring a simple, convenient and affordable diabetes management solution to people with diabetes, healthcare teams and population management programs.
The iGlucose solution, which uses cell-enabled technology to automatically transmit real-time blood glucose results, removes complex technology issues by automatically transmitting real-time blood glucose (BG) results that can be viewed and acted on by a healthcare team.
With the integration of iGlucose into the Validic platform, health systems and corporate wellness leaders can now offer an effective diabetes management program that fits easily into busy lives. When an iGlucose user checks their blood glucose, the healthcare team can receive near real-time, actionable data and has the information to confidently treat their patients.
This integration demonstrates Validic’s ongoing commitment to deliver personal health data simply and seamlessly into the healthcare system and to continue to build connections to market-leading connected medical health devices and wearables. By providing tools that enable the access to and analysis of personal health data, Validic powers scalable, personalized and data-driven wellness and remote care programs that offer organizations a critical competitive advantage in an increasingly crowded market.
“At Smart Meter, we deliver reliable, accurate data through our cellular connected iGlucose platform. Complicated and costly technology will not be readily adopted by most people and presents a major barrier to usage. iGlucose keeps data management simple and eliminates unnecessary steps and equipment to transfer health information. Patient data can be easily shared in real-time so individuals and populations can be managed more effectively and efficiently,” says Cliff McIntosh, CEO of Smart Meter, LLC. “Our collaboration with Validic enables us to seamlessly provide data to a wider group of healthcare professionals, integrate data into various health records and assist in delivering better care to those that need the most attention.”
“We are excited to welcome iGlucose to Validic’s device ecosystem,” said Validic CEO Drew Schiller. “Both of our organizations are committed to improving the management of chronic conditions through the elevation of personal health data to clinical care teams. By combining real-time device data with programmatic care, we can deliver a healthcare experience personalized to the unique needs of a patient and designed for clinician efficiency. Through this partnership, we continue to broaden access to key clinical insights – generated outside the clinical setting – that are necessary to provide effective and targeted treatments and interventions.”
Affordable and easy to use, the iGlucose Solution eliminates the day-to-day hassles of cables, synching devices and downloading apps for people with diabetes. Healthcare teams can easily engage patients by viewing real-time results and seeing when their patients’ BG results are out of range. iGlucose enables and supports the new CMS reimbursable remote patient monitoring program (CPT 99091) that requires patient-generated, digitally stored data.
To learn more about how the iGlucose Cellular Diabetes Care Solution can simplify diabetes management for people with diabetes, watch this short explainer video.